Services
Galleri Multi-Cancer
Early Detection in Miami
One blood draw, ordered and reviewed by a board-certified physician, screening for a shared cancer signal across more than 50 cancer types. Many of these cancers have no recommended screening today.
Self-pay $1,150. Complements your standard screenings. It does not replace them.
Joint Commission AccreditedThe only one in Florida
What is the Galleri multi-cancer early detection test?
Galleri, made by GRAIL, is a blood-based test that looks for a single shared cancer signal across more than 50 cancer types. It reads DNA methylation patterns in cell-free DNA, the genetic fragments cancer sheds into the bloodstream. When a signal is found, the test also predicts where in the body it most likely came from.
The draw takes about ten minutes at our Surfside clinic, two small tubes of blood. GRAIL analyzes the sample, and results return in roughly two weeks. You review them in person or by telehealth with a TrufaMED physician, who explains what the result means and what, if anything, comes next. This is a screening tool, not a diagnosis, and it is most useful for the cancers that current screening programs miss entirely.
From one draw to a clear plan
Galleri is built around a focused workup. Because the test predicts a likely tissue of origin, a positive result points your physician toward a specific next step rather than a body-wide search.
The blood draw
Two tubes drawn into GRAIL’s preservatives at our Surfside lab. About ten minutes, no fasting or prep required.
Lab analysis
GRAIL examines methylation patterns in your cell-free DNA to look for a shared cancer signal. Results return in roughly two weeks.
Physician review
Your TrufaMED physician reviews the full report with you, in person or by telehealth, and explains exactly what it shows.
Targeted next steps
If a signal is detected, imaging is chosen to match the predicted origin, and we coordinate any referrals and specialist care from there.
The cancers standard screening misses
Mammography, colonoscopy, low-dose CT, Pap, and PSA are essential, and Galleri replaces none of them. Its value is the cancers that have no recommended screening at all, where most cases are found late.
Roughly 70 percent of cancer deaths in the United States are from cancers without a recommended screening test. For many of those, a person has no way to catch the disease early, because there is simply nothing to look with. Galleri adds a blood-based signal for that gap, and it can shift detection to an earlier stage where treatment options are broader.
Pancreatic cancer
No effective population screening exists. Galleri can surface a signal before the typical late, symptomatic presentation.
Liver and bile duct
Survival drops sharply from early to late stage. Catching a signal earlier genuinely changes the path of care.
Esophageal and stomach
Rising incidence and aggressive biology, with endoscopy too invasive to serve as a population-level screen.
Ovarian cancer
Often silent until advanced, with no recommended screening for average-risk adults in the United States.
Head and neck
Oropharyngeal and laryngeal cancers are routinely found in symptomatic stages, with no dedicated screening pathway.
And many more
Galleri screens for a signal across more than 50 cancer types in a single draw, far beyond what routine screening covers.
Is Galleri right for you?
Galleri is designed for adults at higher risk, where adding detection capability for unscreened cancers is most valuable. A physician confirms it fits your situation before you test.
The test is intended for adults aged 50 and older, the group with the highest baseline cancer risk. It is also appropriate for adults under 50 who carry elevated risk: a strong family history of cancer, a known cancer-predisposition mutation, a prior cancer history, or heavy environmental exposure. Your TrufaMED physician evaluates your history and decides whether Galleri makes sense for you.
Good candidates often include
Adults 50 and older who want detection beyond standard screening, people with a strong family history of cancer, individuals with a known genetic predisposition such as a BRCA or Lynch syndrome mutation, cancer survivors monitoring for a second primary cancer alongside their oncologist, and health-conscious adults who want the fullest picture of their risk. If you are weighing inherited risk, our Empower hereditary cancer screening and Horizon genetic carrier screening look at the genes you were born with, while Galleri looks for a signal of cancer that may be present now. Many patients use them together.
It complements, never replaces, standard screening
Whether or not Galleri finds a signal, keep every recommended screening on schedule: your mammogram, colonoscopy, cervical screening, low-dose CT, and PSA where indicated. Galleri adds to the standard of care, it does not stand in for it. See how it fits into your broader preventive care plan.
A strong evidence base, ordered by a physician
Galleri rests on one of the largest evidence bases in cancer screening, and at TrufaMED every step is led by a board-certified MD, not a mail-in kit.
Large study program
Galleri’s development includes the Circulating Cell-Free Genome Atlas studies, the PATHFINDER cohort, the PATHFINDER 2 registrational study of 35,878 participants, and the NHS-Galleri trial in the United Kingdom with more than 140,000 participants.
Predicts the origin
When a signal is found, Galleri predicts the most likely tissue of origin, so the diagnostic workup is targeted to one organ system rather than a broad, anxious search across the whole body.
Physician-ordered and reviewed
Every order, interpretation, and follow-up at TrufaMED is delivered by a board-certified physician at a Joint Commission-accredited, CLIA-certified facility, the only one in Florida.
Honest about the limits
Galleri is a CLIA Laboratory Developed Test, not FDA-approved, and it is one screening tool among several. We explain the false-positive rate and what the test cannot tell you before you decide.
On-site lab and imaging
The draw happens at our own diagnostic lab, and if follow-up is needed, on-site digital X-ray and coordinated imaging keep your workup moving without delay.
Built into concierge care
Galleri pairs naturally with a concierge membership, where annual screening, results review, and coordination are handled by a physician who knows your full history.
What the Galleri test costs
Galleri is self-pay, with a single price set by GRAIL. Your visit includes the physician work that makes the result meaningful.
- Physician consultation and test order
- Blood draw at our Surfside diagnostic lab
- GRAIL laboratory analysis of your sample
- Results review visit with a board-certified physician
- A personalized plan for next steps and screening cadence
Galleri is not currently covered by commercial or Medicare insurance. The price is set by GRAIL. The test is HSA and FSA eligible when ordered by a physician, which we do as a standard part of the workflow. Follow-up imaging or specialist referrals, if a cancer signal is detected, are billed separately. Questions about coverage? See our insurance page.
Led by a surgeon and an ER physician
A cancer-screening result is only as useful as the physician who interprets it. At TrufaMED, two board-certified MDs order and review every Galleri test.
Dr. Gedalia earned his medical degree from Louisiana State University and completed his surgical residency at St. Vincent’s Hospital in New York. His surgical and oncologic experience shapes how TrufaMED interprets a cancer signal and coordinates the imaging, biopsy, and specialist care that may follow.
Dr. Naidoo brings extensive adult and pediatric emergency, trauma, and critical-care experience from high-volume emergency departments across the East Coast. He brings calm, clear judgment to a sensitive result, walking you through what it means and what to do next.
TrufaMED carries Joint Commission accreditation, a distinction held by only eight urgent care centers in the United States. It is the same standard applied to major hospitals, and it governs every part of our diagnostic and screening work.
Galleri multi-cancer early detection, answered
What patients across Miami, Miami Beach, Bal Harbour, and Surfside ask before testing.
What does a ‘Cancer Signal Detected’ result mean?
It means Galleri identified DNA methylation patterns consistent with cancer in your blood sample, and predicts a Cancer Signal Origin, the most likely tissue of origin. This is not a diagnosis. It is a strong indication that targeted diagnostic workup is needed. Your TrufaMED physician reviews the report with you, explains the predicted origin, and coordinates the focused imaging and referrals specific to that organ system.
Is Galleri FDA-approved?
No. Galleri is offered as a Laboratory Developed Test under CLIA certification by GRAIL. It is not currently FDA-approved or cleared. Performance data comes from GRAIL’s CCGA, PATHFINDER, and STRIVE studies. Your physician will explain what the test can and cannot tell you before you decide to proceed.
What is the false-positive rate?
In GRAIL’s published data, the false-positive rate is roughly 0.5 percent, meaning about 1 in 200 people without cancer will receive a Cancer Signal Detected result that does not correspond to cancer on workup. We discuss this clearly before testing so you understand the possibility going in.
Does insurance cover the Galleri test?
Not currently. Galleri is self-pay only at $1,150, a price set by GRAIL. The test is HSA and FSA eligible when ordered by a physician, which TrufaMED does as a standard part of the workflow.
Can Galleri replace my mammogram or colonoscopy?
No. Galleri is complementary to standard cancer screening, not a replacement. Mammography, colonoscopy, cervical screening, low-dose CT, and PSA where indicated remain the standard of care. Galleri adds detection for many cancers that have no routine screening test at all.
How often should I retest?
GRAIL’s recommended cadence is annual testing for adults 50 and older at elevated risk. Your TrufaMED physician personalizes the cadence based on your overall risk profile, family history, and prior results.
How long does the blood draw take?
About 10 minutes total for the visit. Two tubes of blood are drawn into the special preservatives GRAIL provides, then shipped to the GRAIL laboratory. Results typically return in about two weeks, and you review them with a TrufaMED physician.
Can I take Galleri before age 50?
Yes, with a physician evaluation. Patients with a strong family history of cancer, a known cancer-predisposition mutation, a prior cancer history, or heavy environmental risk factors are reasonable candidates under 50. Your TrufaMED physician determines clinical appropriateness for your situation.
What if the test detects a signal but the follow-up is negative?
This can happen, given the roughly 0.5 percent false-positive rate. If follow-up imaging and workup find no cancer, we typically recommend repeating Galleri in 12 months and continuing your standard-of-care screening on schedule. Your physician guides the plan and stays involved throughout.
How is my genetic and health data protected?
GRAIL is HIPAA compliant and does not share identifiable data with third parties without your consent. The federal GINA law prevents health insurance and employment discrimination based on genetic test results, though GINA does not extend to life, disability, or long-term care insurance. Your physician reviews these protections with you before testing.
Galleri is an investigational Laboratory Developed Test offered under CLIA, not FDA-approved. It does not detect all cancers and a negative result does not rule cancer out. Continue all recommended screenings. For a true emergency, call 911.
What patients say
Best clinic ever
Excellent. Attentive clean
The staff is very nice and courteous
Very nice receptionist
Best place I’ve been to by far great service
The staff are amazing, from front desk, registration, nurse , the Dr. A mean the facility very clean, conftuble, I'll give them 150% plus on everything and all. Thank you so very much
Care grounded in recognized authorities
Galleri is a CLIA-validated multi-cancer early detection test, ordered by a physician and used alongside standard cancer screening, not instead of it. These independent sources are offered for further reading.
Find the right care
Find us in Surfside
Hours
Monday–Friday 9 AM – 9 PM
Saturday 11 AM – 11 PM
Sunday 12 PM – 8 PM
Galleri draws are scheduled with a physician consult.
Contact
Phone (305) 537-6396
WhatsApp +1 (305) 842-9801
Email [email protected]
For a life-threatening emergency, call 911. TrufaMED treats non-life-threatening conditions.
Catch what standard screening cannot
Talk with a TrufaMED physician about whether Galleri multi-cancer early detection is right for you. One conversation, one blood draw, a clearer picture of your health.
Notes from your physicians, every other week.
Seasonal health for South Florida, what we are seeing at the clinic, and the occasional thing worth knowing. No spam, and you can leave anytime.
TrufaMED, in your pocket.
Book urgent care, IV therapy, HBOT and telehealth, track your wellness, and reach your care team, all from the app.